Ophthalmia neonatorum is conjunctivitis occurring in a newborn during the first month of life.
It is also called neonatal conjunctivitis.
Organisms causing neonatal conjunctivitis are usually acquired from the infected birth canal of the mother during vaginal delivery, though some may acquire the infection from their immediate surroundings.
It is one of the leading cause of blindness in infants via corneal ulceration and subsequent opacification or perforation and endophthalmitis.
Workowski KA, Berman S, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR. 2010 Dec;59(RR-12):1-110. http://www.ncbi.nlm.nih.gov/pubmed. Accessed 01 Jun 2012. PMID: 21160459
Mabry-Hernandez I, Oliverio-Hoffmann R. Ocular prophylaxis for gonococcal ophthalmia neonatorum: evidence updated for the U.S. preventive services task force reaffirmation recommendation statement. Agency for Healthcare Research and Quality (AHRQ) publication. 2010 Aug
Chang K, Cheng VY, Kwong NS. Neonatal haemorrhagic conjunctivitis: a specific sign of chlamydial infection. Hongkong Med J. 2006 Feb;12(1):27-32. PMID: 16495586
Mallika PS, Asok T, Faisal HA, et al. Neonatal conjunctivitis - a review. Malaysian Family Physician. 2008;3(2). Accessed 06 Sep 2012
Olitsky S, Hug D, Plummer L, et al. Ophthalmia neonatorum. In: Kliegman RM, Stanton BF, St Geme JW III, et al, eds. Nelson textbook of Pediatrics. 19th ed. Philadelphia: Saunders, Elsevier; 2011
Rubenstein J, Virasch V. Neonatal conjunctivitis (ophthalmia neonatorum). In: Yanoff M, Duker JS, et al. Ophthalmology. 3rd ed. Maryland Heights, MO: Mosby, Elsevier; 2009
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.